Clinical trial
A Randomized Triple-blind Study Protocol Comparing Polidocanol Versus Hypertonic Glucose for Sclerotherapy in Treatment of Reticular Veins at the Lower Limbs.
NCT02054325 is registered in ClinicalTrials.gov with UPECLIN HC FM Botucatu Unesp as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Triple-blind Study Protocol Comparing Polidocanol Versus Hypertonic Glucose for Sclerotherapy in Treatment of Reticular Veins at the Lower Limbs.
- Lead sponsor
- UPECLIN HC FM Botucatu Unesp
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2012
- Completion date
- December 31, 2014
- Enrollment
- 106 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.